Cargando…
Melanocortin 2 Receptor Antagonists in Canine Cushing’s Disease: In Vitro Studies
Melanocortin 2 receptor antagonists in canine Cushing’s disease: in vitro studies Cushing’s disease (CD), caused by an ACTH-secreting pituitary adenoma, is one of the most common endocrinopathies in dogs. The current medical treatment options involve adrenocortical steroid synthesis inhibitors, but...
Autores principales: | Sanders, Karin, Slob, Adri, Betz, Steven F, Kooistra, Hans S, Galac, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090140/ http://dx.doi.org/10.1210/jendso/bvab048.1654 |
Ejemplares similares
-
PMON284 Triamcinolone Cream-Induced Cushing Syndrome
por: Sacco, Susana Barreiro, et al.
Publicado: (2022) -
SAT-741 Salivary Cortisol and Cortisone Measurement Provide a Novel and Non-Invasive Method of Monitoring Medical Therapy in Cushing’s Syndrome
por: Manson, Megan Elizabeth, et al.
Publicado: (2020) -
Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies
por: Sanders, Karin, et al.
Publicado: (2018) -
The Effect of a Novel Glucocorticoid Receptor Antagonist (CORT113176) on Glucocorticoid and Insulin Receptor Sensitive Hepatic Gene (mRNA) Expression in a Neonatal Rat Model of Human Prematurity
por: Gehrand, Ashley, et al.
Publicado: (2021) -
SUN-739 Next Generation AR Antagonists Increase Systemic Active Glucocorticoid Exposure by Altering Glucocorticoid Metabolism
por: Alyamani, Mohammad, et al.
Publicado: (2020)